BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31550641)

  • 1. Prospective evaluation of oral cannabis extracts in children with epilepsy.
    Knupp KG; Rice JD; Helmkamp LJ; Galinkin J; Sempio C; Jost K; Chapman KE
    Seizure; 2019 Nov; 72():23-27. PubMed ID: 31550641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study.
    Mitelpunkt A; Kramer U; Hausman Kedem M; Zilbershot Fink E; Orbach R; Chernuha V; Fattal-Valevski A; Deutsch L; Heffetz D; Sacks H
    Epilepsy Behav; 2019 Sep; 98(Pt A):233-237. PubMed ID: 31394352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy.
    Press CA; Knupp KG; Chapman KE
    Epilepsy Behav; 2015 Apr; 45():49-52. PubMed ID: 25845492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.
    Reithmeier D; Tang-Wai R; Seifert B; Lyon AW; Alcorn J; Acton B; Corley S; Prosser-Loose E; Mousseau DD; Lim HJ; Tellez-Zenteno J; Huh L; Leung E; Carmant L; Huntsman RJ
    BMC Pediatr; 2018 Jul; 18(1):221. PubMed ID: 29981580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.
    Hausman-Kedem M; Menascu S; Kramer U
    Brain Dev; 2018 Aug; 40(7):544-551. PubMed ID: 29674131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current status of artisanal cannabis for the treatment of epilepsy in the United States.
    Sulak D; Saneto R; Goldstein B
    Epilepsy Behav; 2017 May; 70(Pt B):328-333. PubMed ID: 28254350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients.
    Treat L; Chapman KE; Colborn KL; Knupp KG
    Epilepsia; 2017 Jan; 58(1):123-127. PubMed ID: 27859038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience.
    Tzadok M; Uliel-Siboni S; Linder I; Kramer U; Epstein O; Menascu S; Nissenkorn A; Yosef OB; Hyman E; Granot D; Dor M; Lerman-Sagie T; Ben-Zeev B
    Seizure; 2016 Feb; 35():41-4. PubMed ID: 26800377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsy.
    Gherzi M; Milano G; Fucile C; Calevo MG; Mancardi MM; Nobili L; Astuni P; Marini V; Barco S; Cangemi G; Manfredini L; Mattioli F; De Grandis E
    Complement Ther Med; 2020 Jun; 51():102402. PubMed ID: 32507423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
    Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
    Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of oral delta-9 tetrahydrocannabinol (THC) in children receiving cannabis extracts for epilepsy.
    Wang GS; Bourne DWA; Klawitter J; Sempio C; Chapman K; Knupp K; Wempe MF; Borgelt L; Christians U; Heard K; Bajaj L
    Clin Toxicol (Phila); 2020 Feb; 58(2):124-128. PubMed ID: 31111749
    [No Abstract]   [Full Text] [Related]  

  • 16. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
    Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series.
    Nowicki M; Bourgeois-Tardif S; Diaz PL; Hebert FO; Sanon NT; Champagne PO; Major P; Sell E; Bitton J; Lewis E; Weil AG
    Can J Neurol Sci; 2022 Jul; 49(4):595-597. PubMed ID: 34183079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.
    Lattanzi S; Brigo F; Trinka E; Zaccara G; Cagnetti C; Del Giovane C; Silvestrini M
    Drugs; 2018 Nov; 78(17):1791-1804. PubMed ID: 30390221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
    Hess EJ; Moody KA; Geffrey AL; Pollack SF; Skirvin LA; Bruno PL; Paolini JL; Thiele EA
    Epilepsia; 2016 Oct; 57(10):1617-1624. PubMed ID: 27696387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.